G. E. Lunniss

The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.

Roseanne Norris, D. Montanari, Ashley A. Barnes, 2009, Bioorganic & medicinal chemistry letters.

The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.

P. Procopiou, V. Barrett, G. Somers, 2011, Bioorganic & medicinal chemistry.

The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.

R. Perciaccante, Valerie S. Morrison, P. Procopiou, 2011, Bioorganic & medicinal chemistry.

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.

J. Willis, D. Montanari, Ashley A. Barnes, 2010, Bioorganic & medicinal chemistry letters.

Abstract 5371: PRMT5 inhibitors as novel treatment for cancers

T. Peat, P. Pilling, S. Jane, 2015 .

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.

J. Willis, D. Montanari, Ashley A. Barnes, 2010, Bioorganic & medicinal chemistry letters.